Return to article

TABLE 4. Composition of nine DTaP vaccines evaluated in efficacy trials^a

Vaccine^b Amt of B. pertussis antigens (µg/dose)
Amt. of aluminum (mg/dose) Preservative Flocculation^c

PT FHA PRN FIM Diphtheria toxoid Tetanus toxoid

Certiva^d 40 0.50 Thimerosal 25 7

Tripedia^d 23.4 23.4 0.17 Thimerosal 6.7 5

PM-2^e 25 25 0.30 Thimerosal 15 5

SKB-2^e 25 25 0.50 Phenoxyethanol 25 10

Acelluvax 5 2.5 2.5 0.35 Thimerosal 25 10

Infanrix^d 25 25 8 0.50 Phenoxyethanol 25 10

ACEL-IMMUNE^d 3.5 35 2 0.8^f 0.23 Thimerosal 9 5

DAPTACEL^d 10 5 3 5^g 0.33 Phenoxyethanol 15 5

Daptacel-like (enhanced) 20 20 3 5^g 0.33 Phenoxyethanol 15 5

^a Data from references 149 and 216.

^b Trade names.

^c Limit of flocculation per dose.

^d Licensed in the United States.

^e No product name.

^f FIM2.

^g FIM2/3.

Return to article